InnerCool, a wholly-owned subsidiary of Cardium Therapeutics, Inc. (NYSE Amex: CXM), will be acquired in an asset purchase transaction for 11.25 million dollars, as well as the transfer of approximately 1.5 million dollars in trade payables. The transaction will reinforce Philips
Latest Articles
InnerCool, a wholly-owned subsidiary of Cardium Therapeutics, Inc. (NYSE Amex: CXM), will be acquired in an asset purchase transaction for 11.25 million...